Description of the largest cluster of tuberculosis notified in Norway 1997–2011: is the Norwegian tuberculosis control programme serving its purpose for high risk groups? by unknown
Guzman Herrador et al. BMC Public Health  (2015) 15:367 
DOI 10.1186/s12889-015-1701-xRESEARCH ARTICLE Open AccessDescription of the largest cluster of tuberculosis
notified in Norway 1997–2011: is the Norwegian
tuberculosis control programme serving its
purpose for high risk groups?
Bernardo R Guzman Herrador1,2*, Karin Rønning1, Katrine Borgen1, Turid Mannsåker1 and Ulf R Dahle1Abstract
Background: Approximately 90% of new tuberculosis (TB) cases notified in Norway are asylum seekers and other
immigrants from high-incidence countries. Asylum seekers are screened upon arrival at the National Immigration
Centre. Other immigrants receive a letter from the Municipal Health Services requesting that they present for
screening in their municipality of residence. In order to identify potential areas where the TB control programme
could be better adapted for these groups, we studied the largest cluster of TB cases (“cluster X”) notified in Norway
until 2011.
Methods: Cases were defined as TB notifications reported to MSIS between January 1997 and December 2011 with
identical IS6110 RFLP assigned to cluster X. We described the cases in cluster X by using data from the Norwegian
Surveillance System for Communicable Diseases (MSIS). Missing or incomplete information in MSIS was obtained
from the National Reception Centre, Oslo University Hospital and Municipal Health services.
Results: Of a total of 44 individuals meeting the case definition, 36 originated from Somalia and eight from other
high-incidence countries. Twenty nine were asylum seekers and 15 were other immigrants. Upon arrival, 18/44 had
been diagnosed with latent TB infection (LTBI), 9/44 tested negative for LTBI and 4/44 had been diagnosed with active
TB. Results of TB-screening upon arrival were not available for the remaining 13/44 (one asylum seeker and 12 other
immigrants). Five of the 12 other immigrants had still not been screened for TB after staying one year or longer in
Norway.
Conclusions: Most cases in cluster X with available results of TB-screening were already infected at arrival, indicating
that their disease could be due to endogenous reactivation, rather than recent transmission after arrival to Norway.
TB-status upon arrival was unknown for many of the other immigrants due to lack of initial screening. The reasons why
conduction of the initial screening among other immigrants is failing should be explored and methods to simplify the
TB screening at arrival should be implemented.
Keywords: Tuberculosis, Control programme, Cluster, Elimination* Correspondence: BernardoRafael.Guzman.Herrador@fhi.no
1Division of Infectious Disease Control, Norwegian Institute of Public Health,
Oslo, Norway
2European Programme for Intervention Epidemiology Training (EPIET),
European Centre for Disease Prevention and Control (ECDC), Stockholm,
Sweden
© 2015 Guzman Herrador et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public
Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this
article, unless otherwise stated.
Guzman Herrador et al. BMC Public Health  (2015) 15:367 Page 2 of 5Background
In 2012, the European Union/European Economic Area
member states reported 68,423 tuberculosis (TB) cases
(13.5 per 100,000 population) [1]. Norway has a low no-
tification rate of TB (401 cases notified in 2012; around
8 cases per 100,000 inhabitants) [1,2]. The incidence of
TB in Norway, as in many other industrialized countries,
has steadily decreased in the native-born population
during the last decades. Following increased immigration
from high incidence countries, the number of reported
cases in the foreign-born population has increased since
the late 1980s [2,3], leading to an increase in the number
of TB cases notified during the first decade of the 21st
century. TB transmission rates are however low, as the
majority of TB cases are generated through re-activation
of latent TB infection (LTBI) acquired abroad or domes-
tically in a distant past [4]. In 2013, 86% of the TB cases
in Norway were foreign-born, mainly from African
countries [2]. Surveillance and screening of high risk
groups is critical for the effective prevention and control
of spread of TB in low-incidence countries and it is
mandatory, including screening for LTBI, in Norway [5].
The WHO has developed a post-2015 Global TB Strat-
egy, which was endorsed by the World Health Assembly
in May 2014 [6]. The pillars and components of this
strategy include management of LTBI in people with a
high risk of developing active TB. This is considered one
essential component if low-incidence countries are to
eliminate TB. It has been shown that even in low-
incidence countries certain groups are still at high risk
of developing active TB. Therefore, TB control pro-
grammes should be adapted to identify and target these
groups specifically [7].
In Norway, information on newly diagnosed TB cases
is reported by medical specialists and microbiological la-
boratories to the Norwegian Institute of Public Health
(NIPH), where the information is entered into the
Norwegian Surveillance System for Communicable Dis-
eases (MSIS). Clinical and laboratory data are linked in
MSIS through the personal identification number of
each case. All Mycobacterium tuberculosis isolates are sent
to the National Reference Laboratory for Mycobacteria at
the NIPH for confirmation and further characterization.
Since 1994 all strains are genotyped using IS6110 restric-
tion fragment length polymorphism (RFLP), and since
2011 by use of mycobacterial interspersed repetitive units
typing (MIRU). Cases are assigned a cluster number when
identical strains are identified.
The Norwegian TB control programme was developed
throughout the 20th century and it has been revised
regularly to be able to meet its purpose. As in many
other low-incidence countries, the operability of the na-
tional TB control programme has been continuously
challenged due to the increased immigration from high-incidence countries from numerous parts of the world
followed by shift in the TB epidemiology, which has
prompted revision of control programmes [8].
In this paper, we studied the largest cluster of TB cases
(“cluster X”) notified in Norway until December 2011,
with focus on screening procedures and results, in order
to identify potential areas where the TB control
programme could be better adapted to high-risk groups
in low-incidence countries.Methods
Routine TB surveillance and control among immigrants in
Norway
Asylum seekers entering Norway are admitted to the
National Reception Centre in Oslo for around three
days where they undergo medical screening, including
TB symptom screening, a tuberculin skin test and
chest X-ray (for those 15 years or older). Suspected TB
cases are referred to the Oslo University Hospital for
diagnosis, clinical isolation and treatment. After initial
screening, most asylum seekers move to local centres
throughout the country. TB screening results are for-
warded to municipal health services (MHS) in the mu-
nicipality of residence for further follow up [9]. If the
residence-application is rejected, the asylum seeker will
not be deported while on treatment for active TB [4].
Other immigrants (refugees, students, workers, family
reunion) from high-incidence countries [10] are also re-
quired by regulation to undergo TB screening. They re-
ceive a letter at their personal address from the MHS in
which they are requested to contact the MHS for TB
screening within four weeks [9]. The screening includes
tests that are conducted on different days and at various
locations.
The MHS are responsible for assessment and follow-
up of TB screening results of asylum seekers and other
immigrants, including both LTBI and active TB, and re-
ferring patients to the specialist health care for diagnosis
and treatment. In order to facilitate such follow-up, all
hospitals with TB care units have appointed one or more
TB coordinators. In collaboration with medical expertise,
they are responsible for developing personal treatment
plans, individual follow-up and communication with all
patients [9].Data gathering
Cases were defined as TB notifications reported to MSIS
between January 1997 and December 2011 with identical
IS6110 RFLP assigned to cluster X. We selected the cases
from the MSIS database and extracted the following vari-
ables: Age at time of diagnosis, sex, immigration reason
(asylum seeker or other immigrant), country of birth, date
of first arrival to Norway (month/year), date of first TB
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negative (Mantoux <6 mm; Pirquet ≤ 5 mm), positive
(Mantoux ≥ 6 mm; Pirquet > 5 mm), or active disease, date
of diagnosis (month/year), clinical presentation (pulmonary,
lymph node, osteal, other).
Missing or incomplete information in MSIS was ob-
tained from the historical records available at the National
Reception Centre, Oslo University Hospital, or the individ-
ual TB coordinators.
We present the results section divided into “asylum
seekers and “other immigrants” as the screening proce-
dures are different in these two groups.
Ethics statement
At NIPH, all M. tuberculosis strains are routinely col-
lected for disease surveillance purposes. Also, the
Norwegian Act relating to control of communicable dis-
eases [11] obliges NIPH to monitor the TB situation
within the country on a continuous basis, including col-
lecting and collating case based epidemiological and
microbiological information. For these reasons, ethical
approval was not required for this study. All the epi-
demiological information analysed and included in the
current manuscript is anonymized.
Results
From January 1997 to December 2011, there were 4,367 TB
notifications in MSIS, of which 3,449 were culture posi-
tive and 3,275 were analysed by IS6110 RFLP. Of these
3,149 (96%) were unique or assigned to clusters with
less than 10 individuals. A total of 44 cases were assigned
to “cluster X”. Of these, 64% (28/44) were female and 93%
(41/44) were below 40 years old (Figure 1). The number of
cases notified each year ranged from one to six. Half of
the cases (48%; 21/44) had pulmonary TB.
None of the cases were native-born Norwegians. The
majority (82%; 36/44) was originally from Somalia
followed by Ethiopia (two cases) and Ghana, DemocraticFigure 1 Distribution of TB cases by age and sex. Cluster X (n = 44);
Norway, 1997–2011.Republic of Congo, Sudan, Tanzania, Thailand, and
Romania, with one case each.
Upon arrival, 41% (18/44) had been diagnosed with
latent TB infection (LTBI), 20% (9/44) tested negative
for LTBI and 9% (4/44) were diagnosed with active TB.
Results of TB-screening upon arrival were not available
for the remaining 30% (13/44) (Figure 2). The median
time from first arrival in Norway to diagnosis of active
TB was 5.8 years for those who tested negative at arrival
(range = 10 months-14 years; IQR = 10.3 years) and
5.4 years for those with unknown results (range = seven
months-26.8 years; IQR = 12.3 years). Year of arrival was
unknown for two cases.Asylum seekers
One third (34%; 15/44) were asylum seekers who had
been screened upon arrival to Norway at the National
Reception Centre. Screening results were available for
93% of these (14/15). Most of them (64%; 9/14) had been
diagnosed with LTBI, 29% (4/14) tested negative and 7%
(1/14) had active TB (Figures 2 and 3). The median time
from diagnosis of LTBI to the diagnosis of active TB for
these nine cases was 2.6 years, ranging from two months
to 8.4 years (IQR = 5.6 years).Other immigrants
Twenty nine cases (66% of all cases) were not asylum
seekers and resided in 15 different counties at the time
of TB diagnosis. Twelve of them (41%; 12/44) had not
been screened during their first four weeks in Norway,
and their TB status upon arrival was therefore unknown
(Figures 2 and 3). Five of these had not been screened
even after residing in Norway for one year or more.
Among those with screening results available, 53%, (9/17)
had LTBI at first arrival to Norway, 18% (3/17) were diag-
nosed with active TB, and 29% (5/17) tested negative. The
median time from diagnosis of LTBI to the diagnosis of
active TB was ten months, ranging from six months to















Figure 2 Flow chart with screening results at first arrival to Norway.






15 screened at first arrival to Norway* 
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*Screening results for one of them were not found in the records
Figure 3 TB status at first arrival to Norway by type of immigrant. Cluster X (n = 44); Norway, 1997–2011.
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Most cases included in “cluster X” came originally from
the same high-incidence region on the African continent
and were already infected upon first arrival to Norway.
However, although false-negative tuberculin skin tests
results are well known and cannot be excluded [12],
there are indications that cluster X also included individ-
uals who may have become infected in Norway, as nine
of them tested negative for LTBI at first arrival. Despite
the possibility of TB transmission after arrival to
Norway, such events are uncommon and largely limited
to a few immigrant groups [13]. In addition, we have to
bear in mind the possibility of relapse of a previously
cured TB episode among those positive at first arrival
after treatment completion. Previous studies conducted
in Europe have concluded that, although the relapse rate
is usually low, the risk is higher in neighborhoods with
high TB incidence [14]. For this specific investigation we
used surveillance data already collected in MSIS which
did not allow determination of specific social relation-
ships or geographical linkages within the cluster.
By looking in depth into the largest TB cluster re-
ported in Norway we identified several specific areas for
improvement in the TB control programme:
Most of the cases with known screening results had
LTBI at first arrival and developed active TB several
months or years later. In practice, a correct follow up of
LTBI cases is not always achieved and some patients are
not offered or do not accept treatment. In the current
investigation we do not have data available on specific
weaknesses in the follow up of single patient. Our results
support the findings of a previous investigation that
evaluated LTBI screening among asylum seekers in
Norway, which concluded that a minor proportion of
asylum seekers were treated as recommended for LTBI
[15,16]. Reasons for this may be organizational factorsaffecting follow-up and referral, and specialists not fol-
lowing current guidelines [15,16].
Almost one third of the cases had not undergone the
initial TB screening. The proportion of unscreened
cases was considerably higher among immigrants other
than asylum seekers. Many reasons, both logistical and
cultural, may explain this, such as failure to be in-
formed (i.e. failures in the administrative procedures,
change of address, language-barriers), fear of possible
deportation, lack of knowledge about public health
consequences if not performed, or complex processes
that involve different tests in different locations in new
and unfamiliar communities.
Other low-incidence countries such as the United
Kingdom and the United States have stressed the im-
portance of screening and treatment both for LTBI and
active TB in immigrants from high-incidence countries
[17,18]. However, the on-going international debate re-
garding the cost-effectiveness of screening, targeting the
correct groups and choice of screening methods [19,20]
demonstrate that many low-incidence countries experience
numerous challenges in adapting TB control programmes
to the changing epidemiology. Still, compulsory TB screen-
ing for immigrants from high-incidence countries has been
questioned, since most active disease develops after immi-
gration and that early diagnosis has not been shown to con-
vey public health benefits [21].
Our results cannot be considered a full evaluation of
TB screening in Norway as cases in cluster X represent
just a small subset of the total number of TB cases that
occurred in Norway during the study period. However,
we selected cluster X as our study population since it is
by far the largest TB cluster identified in Norway and
there is no reason to think that cases in this cluster have
been screened differently upon entry than other TB
cases in Norway.
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In conclusion, the description of this large TB cluster in
Norway has clearly highlighted areas where the TB con-
trol programme could be better adapted for high risk
groups. This experience may be valuable for other low-
incidence countries and emphasizes that a large pool of
latently infected people contributes to a growing propor-
tion of future TB cases, unless effectively identified,
treated or monitored. In Norway, a stronger collabor-
ation between municipalities, together with a better flow
of information between all stakeholders involved in the
control programme could facilitate a closer individual
follow-up of cases with LTBI at the first screening, pre-
venting development of active TB. In addition, imple-
mentation of measures to simplify and facilitate access
to TB screening at arrival (i.e. ensure that the letter is
sent to the correct address in an understandable lan-
guage to the relevant person; decrease as much as pos-
sible the number of different locations where different
tests are conducted) could increase adherence of immi-
grants to the control programme.
TB elimination should remain an aim for low-
incidence countries. This will however, require political
commitment, financial support and high awareness of
the challenges ahead. Full engagement will include the
sharing of experiences, knowledge and expertise to de-
velop strategies that are adapted to particular popula-
tions moving to and through these countries. If we are
to eliminate TB in this country, the current example
clearly highlights the need to provide additional out-
reach services to high risk groups. This experience is in
accordance with the recommendations given by the 67th
world health assembly the framework for tuberculosis
elimination in low-incidence countries launched by the
World Health Organization in 2014 [6,22].
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